# PUFA Augmentation in Treatment of Major Depression

> **NCT00067301** · PHASE3 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 60 (—)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Polyunsaturated Fatty Acids (PUFA)
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT00067301
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067301, "PUFA Augmentation in Treatment of Major Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00067301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*